⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9111564 | 0.98 | TSHR (0.54) | — | |
| SCHEMBL7646309 | 0.98 | TSHR (0.54) | — | |
| SCHEMBL251339 | 0.98 | TSHR (0.54) | — | |
| SCHEMBL19974043 | 0.98 | TSHR (0.54) | — | |
| SCHEMBL249627 | 0.92 | — | — | |
| SCHEMBL250433 | 0.81 | — | — | |
| SCHEMBL20490085 | 0.81 | — | — | |
| SCHEMBL2371285 | 0.76 | TSHR (0.46) | — | |
| SCHEMBL5174528 | 0.76 | TSHR (0.46) | — | |
| SCHEMBL2371298 | 0.76 | TSHR (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0802920-A2 | ANTIFUNGAL FUSACANDINS | Abbott Laboratories (US) | 1997-10-29 | — | — | EP | claimed |
| WO-1996021670-A2 | ANTIFUNGAL FUSACANDINS | ABBOTT LABORATORIES (US) | 1996-07-18 | — | — | WO | claimed |
| WO-2018050794-A1 | PROCESS FOR PREPARING OF CAROTENOID MONO-ESTERS | BASF SE (DE) | 2018-03-22 | — | — | WO | disclosed |
| WO-2018050792-A1 | PROCESS FOR PREPARING ESTERS OF 12'-APOCAROTENALS AS BUILDING BLOCKS FOR CAROTENOIDS | BASF SE (DE) | 2018-03-22 | — | — | WO | disclosed |
| WO-2018050795-A1 | PROCESS FOR PREPARING OF CAROTENOID MONO-ESTERS | BASF SE (DE) | 2018-03-22 | — | — | WO | disclosed |
| WO-2018050793-A1 | PROCESS FOR PREPARING PHOSPHONIUM SALT ESTERS AS BUILDING BLOCKS FOR CAROTENOIDES | BASF SE (DE) | 2018-03-22 | — | — | WO | disclosed |
| EP-2589058-A1 | PHOTOELECTRIC CONVERSION DEVICE COMPRISING HYDROXAMIC ACID DERIVATIVE OR SALT THEREOF AS ADDITIVE AND PROCESS FOR PRODUCING SAME | BASF SE (DE) | 2013-05-08 | — | — | EP | disclosed |
| WO-2012001628-A1 | PHOTOELECTRIC CONVERSION DEVICE COMPRISING HYDROXAMIC ACID DERIVATIVE OR SALT THEREOF AS ADDITIVE AND PROCESS FOR PRODUCING SAME | BASF SE (DE) | 2012-01-05 | — | — | WO | disclosed |
| EP-2086328-A2 | NOVEL ARYLBICYCLO[3.1.0]HEXYLAMINES AND METHODS AND COMPOSITIONS FOR THEIR PREPARATION AND USE | DOV Pharmaceutical, Inc. (US) | 2009-08-12 | — | — | EP | disclosed |
| WO-2008109556-A1 | NUCLEIC ACID COMPOUNDS FOR INHIBITING TELOMERASE GENE EXPRESSION AND USES THEREOF | MDRNA, INC. (US) | 2008-09-12 | — | — | WO | disclosed |
| WO-2008057575-A2 | NOVEL ARYLBICYCLO[3.1.0]HEXYLAMINES AND METHODS AND COMPOSITIONS FOR THEIR PREPARATION AND USE | DOV PHARMACEUTICAL, INC. (US) | 2008-05-15 | — | — | WO | disclosed |
| EP-0979226-A1 | ISOXAZOLE DERIVATIVES | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 2000-02-16 | — | — | EP | disclosed |
| WO-1999016777-A1 | ANTIFUNGAL CORYNECANDIN | ABBOTT LABORATORIES (US) | 1999-04-08 | — | — | WO | disclosed |
| WO-1998047880-A1 | ISOXAZOLE DERIVATIVES | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 1998-10-29 | — | — | WO | disclosed |
| EP-0802920-A2 | ANTIFUNGAL FUSACANDINS | Abbott Laboratories (US) | 1997-10-29 | — | — | EP | disclosed |
| WO-1996021670-A2 | ANTIFUNGAL FUSACANDINS | ABBOTT LABORATORIES (US) | 1996-07-18 | — | — | WO | disclosed |
| EP-0670831-A1 | QUINOXALINE DERIVATIVE AS ANTIDIABETIC AGENT | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1995-09-13 | — | — | EP | disclosed |
| WO-1995009159-A1 | QUINOXALINE DERIVATIVE AS ANTIDIABETIC AGENT | OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) | 1995-04-06 | — | — | WO | disclosed |